Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07124065

Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with thyroid nodules are currently investigated with ultrasound with or without biopsy. Despite these investigations, a subset of patients remain "indeterminate" whereby a cancer can neither be diagnosed nor ruled out - these patients will usually be recommended to undergo diagnostic surgery. This study aims to assess a new technique called diffuse reflectance spectroscopy to determine if this can differentiate between benign and cancerous nodules, particularly in these indeterminate cases.

Detailed description

Diffuse reflectance spectroscopy is an imaging technique which is conducted via a probe that is placed into direct contact with the tissue. This probe emits light, and simultaneously measures the light reflected back - differences in this reflected light can provide valuable information which may be able to differentiate cancerous from non-cancerous tissue. Several previous studies have proven this technique useful in other tissues, such as the stomach and oesophagus - this study therefore aims to assess its utility for thyroid nodules The spectroscopic probe is used on the tissue that has already been taken from the body as part of the operation, not on the inside of the body itself. The tissue samples being removed will routinely be sent for microscopic analysis to inform the surgeon about the type of tissues present in the area of the body being operated on. The research team will be in the operating theatre and use the optical probe on the tissue samples.The probe will only be used on the tissue after it has been removed by the surgeon; therefore, the probe will not impact on the operation. The overall aim of the study is to determine if this probe is able to differentiate which nodules are benign and which are cancerous.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDiffuse reflectance spectroscopySpectral data collection with diffuse reflectance spectroscopy

Timeline

Start date
2024-03-20
Primary completion
2024-12-31
Completion
2026-03-31
First posted
2025-08-15
Last updated
2025-08-15

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT07124065. Inclusion in this directory is not an endorsement.